Executive Summary
Publicis Groupe S.A. benefits from a $373.9M CDC contract (potential $497.8M with options) for tobacco education, with $275.5M already outlayed, providing stable multi-year revenue through March 2026. This single mega-contract underscores reliable U.S. government demand in health advertising. Investors should monitor option exercises ($123.9M upside) and post-2026 renewals amid funding risks.
Materiality, sentiment, and priority are scored by Gunpowder’s analysis pipeline. How we score filings →
Tracking the trend? Catch up on the prior Mega Contracts Monitor ($100M+) digest from March 29, 2026.
Investment Signals (1)
- Stable revenue from CDC tobacco campaign (HIGH)▲
$373.9M obligated (76% outlayed at $275.5M) under Time & Materials order supports Publicis Groupe's financials through 2026.
Risk Flags (2)
- Execution [MEDIUM RISK]▼
Time & Materials structure exposes to government audits on hours/rates; only 74% of obligation outlayed with $98.4M remaining uncertain.
- Regulatory [HIGH RISK]▼
Extended term to 2026-03-30 vulnerable to federal funding cuts or non-renewal.
Opportunities (2)
- ◆
Unexercised options worth $123.9M could boost revenue if triggered.
- ◆
Potential follow-on contracts in CDC tobacco campaigns post-2026.
Sector Themes (1)
- ◆
Mega Time & Materials contracts like this signal multi-year commitments in NAICS 541810 for campaigns such as tobacco education.
Watch List (2)
- 👁
{"entity"=>"Publicis Groupe S.A.", "reason"=>"Dominates this period's sole mega-contract; tracks revenue stability from gov't work.", "trigger"=>"Q1 2026 earnings mentioning contract outlays or options"}
- 👁
{"entity"=>"CDC Tobacco Campaign Funding", "reason"=>"Determines $98.4M remaining obligation and $123.9M options.", "trigger"=>"FY2026 HHS appropriations or contract modifications"}
Get daily alerts with 1 investment signals, 2 risk alerts, 2 opportunities and full AI analysis of all 1 filings
$30/mo after a 14-day free trial — no credit card required. See pricing or explore intelligence streams.
More from: Mega Contracts Monitor ($100M+)
🇺🇸 More from United States
View all →May 27, 2026
US Pre-Market SEC Filings Roundup — May 27, 2026
US Pre-Market SEC Filings Roundup
May 27, 2026
S&P 500 Technology Sector SEC Filings — May 27, 2026
S&P 500 Technology Sector SEC Filings
May 27, 2026
Orphan Drug Approvals — May 27, 2026
Orphan Drug Approvals
May 27, 2026
Big Pharma Approvals — May 27, 2026
Big Pharma Approvals